|
Invited Speakers:
|
|
Alix Eastham Senior Manager, Ultragenyx Gene Therapy
Amish Patel VP of Technical Operations, Calidi Biotherapeutics
Ashley Winslow President & CSO, Odylia Therapeutics
Biren Mistry Associate Director, Zentalis Pharmaceuticals
Chien-Chung Chen Director, Analytical Development, Cabaletta Bio
Dan Odenwelder Senior Engineer III, Biogen
Dan Shelly VP Business Development, Prescient Therapeutics
Gargi Roy Associate Director, AstraZeneca
Hemant Khanna VP, Iveric bio
Irina Klimanskaya Senior Director, Astellas Institute for Regenerative Medicine
Jack Scarcelli Director, Head of Cell Science and Technology, Pfizer Ltd
John Rossi Vice President, CARGO Theraputics
Kenneth Green Senior Director, Vertex Pharmaceuticals
Kerry Sieger Senior Director, Global Quality Operations, Immatics US, Inc.
Kumkum Saxena Vice President, Head of Research and Development, Versatope Therapeutics
Mahwish Natalia Associate Director, Takeda
Morten Sogaard Senior Vice President, Gene Therapy Research and Technical Operations, Astellas
Nathan Moore Director, Takeda
Nelly Viseux Senior Vice President,Process & AnalyticalDevelopment & ClinicalManufacturing, 2Seventybio
Nicholas Marshall Head of Protein Sciences, Invenra
Nitin Garg Senior Director, PTC Therapeutics
Paolo Martini CSO, Moderna Inc
Shyam Subramanian Chief Technical Officer, Obsidian Therapeutics
Stefan Haider Associate Director Upstream Development, Boehringer Ingelheim
Stefanie Brady Sr. Director, Supply Chain, REGENXBIO
Taylor Forte Associate Director, Biogen
William Beck Director, Supply Chain, CARISMA Therapeutics
Zhu Zhen Pirot Platform CGT analytical lead, Bayer
|
|
.png)